Pardillo, Madelyn C.
HRN: 26-11-80 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2024
CEFUROXIME 1.5GM (VIAL)
12/11/2024
12/18/2024
IVT
1.5GMS
Q8
NKA
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes